MHRA authorises drug for adults with rare heart muscle damage
News
Genomics study launches to optimise childhood cancer care in Ireland
It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment
UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine
FDA approves Click’s digital therapeutic for episodic migraine
More than 37 million adults in the US are affected by migraine
Leqembi approved as first treatment to slow early Alzheimer’s progression
European Commission grants authorisation for Eisai and Biogen therapy
Pepaxti shows effectiveness in heavily pretreated multiple myeloma patients
New real-world data reinforce treatment benefit
New data reinforce daratumumab as standard of care for multiple myeloma
Long-term survival projections suggest improved outcomes for patients
Global data highlights effectiveness of romosozumab
Studies show improved bone mineral density and healthcare cost reductions
UK clinical trials regulations signed into law
Major update aims to accelerate research and strengthen patient safety
New test prototype for monitoring MGUS patients funded
Birmingham researchers to make MGUS monitoring more efficient
First treatment for common bladder cancer recommended by NICE
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
NHS launches spring COVID-19 booster campaign
An estimated 7.5 million people will be invited to receive the booster
SkyCell and Microsoft partner to improve pharma supply chains
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making
